SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001595585-20-000027
Filing Date
2020-02-28
Accepted
2020-02-28 16:12:15
Documents
15
Period of Report
2020-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcda-20200224.htm   iXBRL 8-K 53091
2 EX-10.1 executiveseverancebene.htm EX-10.1 156571
  Complete submission text file 0001595585-20-000027.txt   385540

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcda-20200224.xsd EX-101.SCH 2574
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcda-20200224_cal.xml EX-101.CAL 720
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcda-20200224_def.xml EX-101.DEF 1684
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcda-20200224_lab.xml EX-101.LAB 25288
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcda-20200224_pre.xml EX-101.PRE 13200
15 EXTRACTED XBRL INSTANCE DOCUMENT tcda-20200224_htm.xml XML 11945
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Filer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38558 | Film No.: 20670176
SIC: 2834 Pharmaceutical Preparations